Overview Growth Response in Girls With Turner Syndrome Status: Completed Trial end date: 2003-05-21 Target enrollment: Participant gender: Summary This trial is conducted in Europe. The aim of the trial is to evaluate growth response of two somatropin dose regimens in girls with Turner Syndrome. Phase: Phase 4 Details Lead Sponsor: Novo Nordisk A/S